Literature DB >> 33144187

Circular RNAs in liver diseases: Mechanisms and therapeutic targets.

Li-Yun Fu1, Shu-Wei Wang2, Meng-Yuan Hu2, Zhen-Luo Jiang3, Li-Li Shen3, Yu-Ping Zhou4, Jun-Ming Guo5, Yao-Ren Hu6.   

Abstract

Circular RNAs (circRNAs) are formed from the genome through diverse back splicing and feature the closed loop. circRNAs are widely available in a variety of cells and characterized by conservation, structural stability, high abundance and tissue-specific or developmental-specific expression. Recent studies have shown that circRNAs are closely related to liver diseases, such as metabolic-associated fatty liver disease, hepatitis, liver cirrhosis and hepatocellular carcinoma. circRNAs play an important role in the progression of liver diseases, are potential diagnostic and prognostic markers, and have translational value in therapy. This article reviews the research on circRNAs in liver diseases, with a view to providing a theoretical basis and new ideas for future research and treatment of liver diseases.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Circular RNA; Hepatitis; Hepatocellular carcinoma; Liver cirrhosis; Metabolic-associated fatty liver disease

Mesh:

Substances:

Year:  2020        PMID: 33144187     DOI: 10.1016/j.lfs.2020.118707

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  3 in total

1.  Depleting circ_0088364 restrained cell growth and motility of human hepatocellular carcinoma via circ_0088364-miR-1270-COL4A1 ceRNA pathway.

Authors:  Kai Sun; Haochen Wang; Dongyuan Zhang; Yupeng Li; Lei Ren
Journal:  Cell Cycle       Date:  2021-12-24       Impact factor: 4.534

Review 2.  Non-coding RNA-associated competitive endogenous RNA regulatory networks: Novel diagnostic and therapeutic opportunities for hepatocellular carcinoma.

Authors:  Sattar Khashkhashi Moghadam; Babak Bakhshinejad; Ali Khalafizadeh; Bashdar Mahmud Hussen; Sadegh Babashah
Journal:  J Cell Mol Med       Date:  2021-12-14       Impact factor: 5.310

3.  Circular RNA: A novel type of biomarker for glioma (Review).

Authors:  Wei Sun; Huandi Zhou; Xuetao Han; Liubing Hou; Xiaoying Xue
Journal:  Mol Med Rep       Date:  2021-06-24       Impact factor: 2.952

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.